Further analysis showed that GKN2 promoter methylation level of stage I, II, and III was significantly higher than the adjacent cancer tissues, indicating GKN2 promoter hypermethylation in NSCLC. The gene discussed is GKN2; the disease is non-small cell lung carcinoma.